NCT02585583View on ClinicalTrials.gov

Deep Brain Frameless Radiosurgery for Drug Resistant Invalidating Tremor. Dose Escalation Pilot Study

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Tremor, Limb
Interventions
RADIATION

Thalamotomy

VoA-Vop complex of the thalamous or VIM nucleus will be targeted. 100 Gy, 120 Gy, 130 Gy, 140 Gy will be the foreseen prescription dose. CyberKnife will be always used to perform the procedure.

Trial Locations (1)

20133

Radiotherapy Unit, Milan

All Listed Sponsors
lead

Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta

OTHER

NCT02585583 - Deep Brain Frameless Radiosurgery for Drug Resistant Invalidating Tremor. Dose Escalation Pilot Study | Biotech Hunter | Biotech Hunter